Alzheimer's disease and diabetes-associated cognitive dysfunction: the microglia link?

Area of Science:

• Neuroscience
• Immunology
• Genomics

Background:

• Alzheimer's disease (AD) involves amyloid-β plaques and tau tangles, leading to dementia.
• Diabetes-associated cognitive dysfunction (DACD) is linked to impaired cognition and memory in diabetes mellitus.
• Microglia play a role in both AD and DACD, but their specific characteristics in these conditions are not well understood.

Purpose of the Study:

• To investigate microglial alterations in Alzheimer's disease and diabetes-associated cognitive dysfunction mouse models.
• To compare microglial frequency, gene expression, cell-cell communication, and subtypes between AD and DACD models.
• To identify potential therapeutic targets for microglial-based interventions in AD and DACD.

Main Methods:

• Utilized single-nucleus RNA sequencing (snRNA-Seq) data from publicly available datasets.
• Performed bioinformatics analyses to assess microglial frequency, gene expression, and cell-cell interactions.
• Analyzed microglia subtypes and transcription factor activity in 5XFAD (AD model) and db/db (DACD model) mice.

Main Results:

• Microglial frequency was elevated in both AD and DACD mouse models compared to controls.
• Only six common upregulated genes were identified in microglia from both disease models.
• CellChat analysis demonstrated distinct cell-cell communication networks for microglia in AD and DACD.
• Significant differences were observed in microglia subtypes and transcription factor profiles between 5XFAD and db/db mice.

Conclusions:

• This study provides novel insights into microglial heterogeneity and function in AD and DACD.
• The findings highlight differences in microglial responses between AD and DACD.
• The identified alterations suggest potential avenues for developing microglial-targeted therapies for both conditions.